The drug development process is fraught with complexities and bottlenecks that can slow progress. To make informed decisions, researchers need access to comprehensive, accurate scientific data, especially when uncovering unexpected benefits or adverse effects during exploratory development.
However, the adoption of costly, resource-intensive technologies can be a significant hurdle. This webinar will demonstrate how integrating high-plex proteomics services can help overcome these barriers, accelerating decision-making throughout drug development. Proteomic insights are increasingly shaping every stage of the drug discovery and development pipeline. By analyzing protein and single-cell interactions, we can gain a deeper understanding of disease mechanisms, immune potency and persistence, immune-related adverse events, and immunosuppression.
Join us to learn how leveraging proteomics services—ranging from spatial proteomics to flow cytometry to ultra-high-plex techniques—can de-risk your projects and provide the broadest immune coverage available, maximizing insights and driving faster, more confident evidence-based decisions.
Please Note: Due to audio issues we are re-recording a portion of this webinar prior to on-demand publication. In the meantime, you can continue to register, and will be notified when the updated recording is available. Thank you for your patience!
Presenters
Stephen A. Williams
Stephen Williams, M.D., Ph.D. has been the Chief Medical Officer at SomaLogic since 2009, and is responsible for Clinical R&D, Medical Affairs and Regulatory and Quality. He oversees clinical application of the SomaScan® Platform and has also had roles in launching the life sciences commercial business, assay development and bioinformatics.
Nina Lane
Nina Lane, Ph.D., has been at Standard BioTools since 2016. She started her industry career as a Field applications specialist within EMEA. After 4 years and relocating to Canada, she worked as a Product applications specialist before becoming a Product Manager in 2021. She is responsible for CyTOF/IMC studies, managing a busy service lab, and executing bioinformatics services. Over the last 9 years, she has worked with Academics, pharmaceuticals, and Biotechs on a variety of studies, from Pre-clinical to Phase 2 studies.
Sponsor
Standard BioTools
Content Partners
Scientist.com
Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.
We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.
Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.
